Prognostic Impact of Biomarkers in Soft Tissue Sarcomas
Author Information
Author(s): Andrej Valkov, Sveinung W. Sorbye, Thomas K. Kilvaer, Tom Donnem, Eivind Smeland, Roy M. Bremnes, Lill-Tove Busund
Primary Institution: University Hospital of Northern Norway
Hypothesis
The study aimed to investigate the prognostic impact of TGF-β1, NF-κB p105, PKC-ζ, and other markers in non-gastrointestinal stromal tumor soft tissue sarcomas.
Conclusion
High expression of TGF-β1 was significantly associated with aggressive behavior and shorter disease-specific survival in non-GIST soft tissue sarcomas.
Supporting Evidence
- TGF-β1 expression was found to be a significant independent negative prognostic factor for disease-specific survival.
- High levels of fascin and NF-κB p105 were also significant indicators for shorter disease-specific survival.
- Multivariate analysis confirmed TGF-β1 as a crucial prognostic marker in non-GIST STS.
Takeaway
This study looked at how certain proteins in tumors can help predict how well patients with soft tissue sarcomas will do. They found that one protein, TGF-β1, is especially important for understanding patient outcomes.
Methodology
The study used tumor samples and clinical data from 249 patients, constructed tissue microarrays, and evaluated marker expression using immunohistochemistry.
Potential Biases
Potential biases may arise from the retrospective nature of the study and the reliance on existing clinical data.
Limitations
The study is retrospective and may have biases related to the selection of patients and data collection.
Participant Demographics
Median age was 59 years, with 56% female participants.
Statistical Information
P-Value
P=0.019 for TGF-β1 as a prognostic factor.
Confidence Interval
95% CI = 1.1–2.4
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website